TITLE

Some Actions of Growth Hormone Release Inhibiting Factor

AUTHOR(S)
Hansen, Aa. Prange; Ørskov, H.; Seyer-Hansen, K.; Lundbæk, K.
PUB. DATE
September 1973
SOURCE
British Medical Journal;9/8/1973, Vol. 3 Issue 5879, p523
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64108181

 

Related Articles

  • Antineoplastic Action of Growth Hormone-Releasing Hormone (GHR Antagonists. Siejka, Agnieszka; Lawnicka, Hanna; Melen-Mucha, Gabriela; Motylewska, Ewelina; Komorowski, Jan; Stepien, Henryk // Recent Patents on Anti-Cancer Drug Discovery;Jan2012, Vol. 7 Issue 1, p56 

    Some of the antagonists of growth hormone-releasing hormone (GHRH) are able to inhibit the growth of various experimental human cancers. The antitumor effects of first antagonists seemed to be dependent mainly on the disruption of pituitary secretion of growth hormone (GH), followed by the...

  • Too stressed to grow.  // Joe Weider's Muscle & Fitness;Feb95, Vol. 56 Issue 2, p26 

    Reports on the possibility that the stress hormone cortisol inhibits growth hormone release. Effect of depression; Insight on testing procedure.

  • Cancer Vaccines for Hormone/Growth Factor Immune Deprivation:A Feasible Approach for Cancer Treatment. Gonz�lez, G.; Lage, A. // Current Cancer Drug Targets;May2007, Vol. 7 Issue 3, p229 

    One of the older and most validated cancer treatments is endocrine therapy. Some tumors are dependent on hormone stimulation for growth, and therefore therapeutic interventions aiming to deprive the cells of the hormone are feasible and have been successful. Tumor growth also depends in some...

  • ORIGINAL ARTICLE Corticotropin-Releasing Hormone Inhibits Nuclear Factor-κB Pathway in Human HaCaT Keratinocytes. Zbytek, Blazej; Pfeffer, Lawrence M.; Slominski, Andrzej T. // Journal of Investigative Dermatology;Dec2003, Vol. 121 Issue 6, p1496 

    Treatment of human HaCaT keratinocytes with corticotropin-releasing hormone modulates cell proliferation and expression of inflammation markers. In this study we report that corticotropin-releasing hormone also inhibits nuclear factor-κB binding and transcriptional activity. Incubating cells...

  • anti-oestrogen (Major drug group).  // Royal Society of Medicine: Medicines;2002, p76 

    The article presents information on anti-estrogen antagonist. It is a term used to describe any of a class of hormone antagonist drugs that usually act directly to prevent the actions of female sex hormones, the estrogens, at in their target tissues. Examples of drugs that act by the direct...

  • Endocrine and Antineoplastic Actions of Growth Hormone-Releasing Hormone Antagonists. Kovács, Magdolna; Schally, Andrew V.; Varga, József L.; Zarándi, Márta // Current Medicinal Chemistry;2008, Vol. 15 Issue 4, p314 

    Potent antagonists of growth hormone-releasing hormone (GHRH) have been developed for the treatment of disorders caused by excessive GHRH or growth hormone (GH) production and for therapy of cancers. GHRH antagonists suppressed the release of GH and insulin-like growth factor (IGF)-I in...

  • Thyrotropin.  // Columbia Electronic Encyclopedia, 6th Edition;Feb2013, p1 

    Thyrotropin (thī″rätrō′pĭn) or thyroid-stimulating hormone (TSH), hormone released by the anterior pituitary gland that stimulates the thyroid gland to release thyroxine. The release of thyrotropin is triggered by the action of thyrotropin-releasing factor (TRF), a...

  • Thyrotropin.  // Columbia Electronic Encyclopedia, 6th Edition;Q1 2017, p1 

    Thyrotropin (thī″rätrō′pĭn) or thyroid-stimulating hormone (TSH), hormone released by the anterior pituitary gland that stimulates the thyroid gland to release thyroxine. The release of thyrotropin is triggered by the action of thyrotropin-releasing factor (TRF), a...

  • Short Stature Caused by a Mutant Growth Hormone. Takahashi, Yutaka; Kaji, Hidesuke; Okimura, Yasuhiko; Goji, Katsumi; Abe, Hiromi; Chihara, Kazuo // New England Journal of Medicine;2/15/96, Vol. 334 Issue 7, p432 

    This article presents a case study of a child with short stature and a mutant growth hormone caused by a single missense mutation in the growth hormone gene. In this boy, the growth hormone not only could not activate the growth hormone receptor, but also inhibited the action of wild-type growth...

  • Urinary Growth Hormone. Jacques, Brett // Townsend Letter for Doctors & Patients;Feb/Mar2002, Issue 223/224, p74 

    Discusses the clinical value and applications of growth hormone (GH). Physiological action of GH and insulin-like growth factors (IGF); Factors exerting influence on the production and release of GH and IGF-1; Association between high levels of IGF-1 and breast or prostate cancer.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics